ÂÜÀòÂÒÂ×

Mike Benecky is an accomplished professional in regulatory affairs, currently serving as Senior Director of Regulatory Affairs at UCB since April 2020, specializing in in vitro diagnostic and digital medical devices. Prior to this role, Mike held the position of Senior Director of Regulatory Affairs at GSK from October 2011 to April 2020, focusing on precision and digital medicine regulatory strategy. Mike's experience further includes a tenure as Senior Director of Regulatory and Clinical Affairs at QIAGEN, where responsibilities encompassed FDA submissions for molecular diagnostics in infectious diseases from June 2006 to October 2011. Earlier in Mike's career, a role as Director of Regulatory and Clinical Science at Digene Corporation from 2001 to 2006 involved developing FDA submissions for the Hybrid Capture Human Papilloma Viral DNA test. Mike's academic credentials include a Ph.D. in Biochemistry, Biophysics, and Molecular Biology from Princeton University and a Bachelor's degree in Biochemistry from the University of Wisconsin-Milwaukee.